$OMER OMEROS CORP Insider Trading
Get free email notifications about insider trading in OMEROS CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in OMEROS CORP. Insider overview, share value development, latest insider transactions and email notifications about new events in OMEROS CORP for free.
IRS Number: 911663741
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: OMER
Company Address: 201 ELLIOTT AVENUE WEST SEATTLE 98119
Phone number: 206-676-5000
Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.
Market Capitalization: $448.03M
Prev close: $10.29
Average Daily Volume: 523,426
Days Low: $10.02
Year Low: $7.20
Year High: $16.80
OMEROS CORP Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 08 2021 | OMER | OMEROS CORP | Demopulos Gregory A MD | CHAIRMAN, CEO & PRE ... | Option Exercise | M | 4.10 | 35,206 | 144,345 | 147,426 | |
| Apr 08 2021 | OMER | OMEROS CORP | Demopulos Gregory A MD | CHAIRMAN, CEO & PRE ... | Option Exercise | M | 4.10 | 37,407 | 153,369 | 182,632 | |
| Apr 08 2021 | OMER | OMEROS CORP | Demopulos Gregory A MD | CHAIRMAN, CEO & PRE ... | Sell | S | 17.76 | 35,206 | 625,259 | 2,026,986 | 2.1 M to 2 M (-1.71 %) |
| Apr 08 2021 | OMER | OMEROS CORP | Demopulos Gregory A MD | CHAIRMAN, CEO & PRE ... | Buy | M | 4.10 | 35,206 | 144,345 | 2,062,192 | 2 M to 2.1 M (+1.74 %) |
| Apr 08 2021 | OMER | OMEROS CORP | Demopulos Gregory A MD | CHAIRMAN, CEO & PRE ... | Sell | S | 17.91 | 37,407 | 669,959 | 2,026,986 | 2.1 M to 2 M (-1.81 %) |
| Apr 08 2021 | OMER | OMEROS CORP | Demopulos Gregory A MD | CHAIRMAN, CEO & PRE ... | Buy | M | 4.10 | 37,407 | 153,369 | 2,064,393 | 2 M to 2.1 M (+1.85 %) |
| Feb 23 2021 | OMER | OMEROS CORP | JACOBSEN MICHAEL A | VP FINANCE AND CAO | Option Exercise | M | 10.27 | 8,100 | 83,187 | 65,000 | |
| Feb 23 2021 | OMER | OMEROS CORP | JACOBSEN MICHAEL A | VP FINANCE AND CAO | Option Exercise | M | 10.27 | 10,000 | 102,700 | 73,100 | |
| Feb 23 2021 | OMER | OMEROS CORP | JACOBSEN MICHAEL A | VP FINANCE AND CAO | Sell | S | 23.28 | 8,100 | 188,568 | 14,000 | 22.1 K to 14 K (-36.65 %) |
| Feb 23 2021 | OMER | OMEROS CORP | JACOBSEN MICHAEL A | VP FINANCE AND CAO | Buy | M | 10.27 | 8,100 | 83,187 | 22,100 | 14 K to 22.1 K (+57.86 %) |
| Feb 23 2021 | OMER | OMEROS CORP | JACOBSEN MICHAEL A | VP FINANCE AND CAO | Sell | S | 22.64 | 10,000 | 226,400 | 14,000 | 24 K to 14 K (-41.67 %) |
| Feb 23 2021 | OMER | OMEROS CORP | JACOBSEN MICHAEL A | VP FINANCE AND CAO | Buy | M | 10.27 | 10,000 | 102,700 | 24,000 | 14 K to 24 K (+71.43 %) |
| Jan 21 2021 | OMER | OMEROS CORP | JACOBSEN MICHAEL A | VP FINANCE AND CAO | Option Exercise | M | 9.37 | 10,000 | 93,700 | 19,188 | |
| Jan 21 2021 | OMER | OMEROS CORP | JACOBSEN MICHAEL A | VP FINANCE AND CAO | Buy | M | 9.37 | 10,000 | 93,700 | 14,000 | 4 K to 14 K (+250.00 %) |
| Jan 21 2021 | OMER | OMEROS CORP | JACOBSEN MICHAEL A | VP FINANCE AND CAO | Sell | S | 19.95 | 9,500 | 189,525 | 4,000 | 13.5 K to 4 K (-70.37 %) |